 This study will examine how an approved drug TriLipix, when used in combination with a statin a drug that lowers blood cholesterol levels, affects the makeup of plaque. Comparison of the effect on the makeup of plaque will be done by using coronary artery CTA, which all participants will have at enrollment and at the end of the study. 